NIH:
- Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) (PAR-23-166) National Institute of General Medical Sciences National Center for Complementary and Integrative Health National Cancer Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke Office of Research on Women’s Health Application Receipt Date(s): Multiple dates, see announcement.
- NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (PAR-23-198) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): Multiple dates, see announcement.
- NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) (PAR-23-206) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): Multiple dates, see announcement.
- Enhancing Use of Harmonized Cognitive Assessment Protocol Data?(R01 Clinical Trial Not Allowed) (RFA-AG-24-032) National Institute on Aging Application Receipt Date(s): October 02, 2023
- Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) (RFA-CA-23-024) National Cancer Institute Application Receipt Date(s): July 07, 2023
- Undergraduate Summer Research Education in Kidney, Urologic, and Hematologic Diseases (R25 Clinical Trial Not Allowed) (RFA-DK-23-013) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): August 30, 2023
- Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed) (RFA-DK-23-019) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 26, 2023
- Integration of Novel Measures for Improved Classification of Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) (RFA-DK-23-020) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 26, 2023
- Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) (RFA-MH-24-120) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
- ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) (PAR-23-199) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Center for Advancing Translational Sciences National Cancer Institute National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 25, 2025
- Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed) (PAR-23-203) National Institute of Allergy and Infectious Diseases John E. Fogarty International Center National Center for Advancing Translational Sciences National Cancer Institute National Eye Institute National Human Genome Research Institute National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Library of Medicine Application Receipt Date(s): September 01, 2023
- Neuropathological Interactions Between COVID-19 and ADRD (R01 – Clinical Trial Not Allowed) (PAR-23-214) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): October 04, 2023
- Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) (RFA-AG-24-025) National Institute on Aging National Cancer Institute Application Receipt Date(s): November 03, 2023
- Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) (RFA-AG-24-026) National Institute on Aging National Cancer Institute Application Receipt Date(s): November 03, 2023
- Limited Competition: National Health and Aging Trends (NHATS) and National Study of Caregiving (NSOC) (U01 Clinical Trial Not Allowed) (RFA-AG-24-037) National Institute on Aging Application Receipt Date(s): September 29, 2023
- Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed) (RFA-AI-23-027) National Institute of Allergy and Infectious Diseases Office of Research on Women’s Health Application Receipt Date(s): October 11, 2023
- Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed) (RFA-DK-23-008) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 18, 2023
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) (RFA-HG-23-017) National Human Genome Research Institute National Cancer Institute National Institute on Aging Office of Research on Women’s Health Application Receipt Date(s): Multiple dates, see announcement.
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) (RFA-HG-23-018) National Human Genome Research Institute National Institute on Aging Office of Research on Women’s Health Application Receipt Date(s): Multiple dates, see announcement.
- NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (PAR-23-178) National Institute of Neurological Disorders and Stroke National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) (PAR-23-194) National Institute on Drug Abuse Application Receipt Date(s): September 07, 2026
- NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) (PAR-23-197) National Eye Institute Application Receipt Date(s): Multiple dates, see announcement.
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) (PAR-23-207) National Institute of Mental Health National Institute on Aging Application Receipt Date(s): September 07, 2026
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional) (PAR-23-208) National Institute of Mental Health National Institute on Aging Application Receipt Date(s): September 07, 2026
- Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) (PAR-23-213) National Institute of General Medical Sciences Application Receipt Date(s): September 05, 2025
- Development and Characterization of Experimental models of post-TBI ADRD (R01 – Clinical Trial Not Allowed) (PAR-23-218) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): September 22, 2023
- Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) (RFA-AG-24-047) National Institute on Aging Application Receipt Date(s): October 30, 2023
- Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed) (RFA-AI-23-038) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): October 11, 2023
- NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) (RFA-DK-23-014) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): September 28, 2023
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) (RFA-MH-24-280) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): Multiple dates, see announcement
- Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed) (PAR-23-195) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): September 15, 2023
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) (PAR-24-210) National Institute of Mental Health Application Receipt Date(s): May 18, 2026
- CCRP Initiative: Chemical Threat Agent Exposure Resource and Coordination Core (ExRC) (U2C Clinical Trial Not Allowed) (RFA-ES-23-009) National Institute of Environmental Health Sciences National Eye Institute National Institute of Allergy and Infectious Diseases National Institute of Neurological Disorders and Stroke Application Receipt Date(s): September 28, 2023
- Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed) (RFA-HG-23-024) National Human Genome Research Institute Application Receipt Date(s): August 15, 2023
- Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed (RFA-HG-23-025) National Human Genome Research Institute Application Receipt Date(s): August 15, 2023
- Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) (RFA-HG-23-026) National Human Genome Research Institute Application Receipt Date(s): March 03, 2025
- Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed) (RFA-HG-23-027) National Human Genome Research Institute Office of the Director, NIH Application Receipt Date(s): October 26, 2023
- The Blood and Marrow Transplant Clinical Trials Network – Core Clinical Centers (UG1 Clinical Trial Optional) (RFA-HL-24-010) National Heart, Lung, and Blood Institute National Cancer Institute Application Receipt Date(s): October 02, 2023
- The Blood and Marrow Transplant Clinical Trials Network – Data Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-HL-24-011) National Heart, Lung, and Blood Institute National Cancer Institute Application Receipt Date(s): October 02, 2023
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (RFA-OD-23-019) Office of the Director, NIH Application Receipt Date(s): November 01, 2023
- Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36) (RFA-OD-23-020) Office of the Director, NIH Application Receipt Date(s): November 01, 2023
NIA:
- PAR-23-174: Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- RFA-AG-24-017: Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed)
- RFA-AG-24-021: Understanding Gene-Environment Interactions in Brain Aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
- RFA-AG-24-022: Quantifying the Impact of Environmental Toxicants on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
- RFA-AG-24-023: Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
- RFA-AG-24-032: Enhancing Use of Harmonized Cognitive Assessment Protocol Data (R01 Clinical Trial Not Allowed)
- RFA-AG-24-036: Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-AG-24-038: Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)